88489-86-5

Upstream product

• 35190-68-2 dimethyl 4,4'-dithiobisbenzoate 
• 1155-51-7 4,4'-Dithiobisbenzoic acid 

Downstream Products

• 176791-66-5 N-butyl-N-4-pentenyl-4-carbomethoxybenzenesulfenamide 
• 1441784-08-2 N-hydroxy-4-((2-methyl-1,2,3,4-tetrahydropyrimido[1,6-a]indol-5-yl)thio)benzamide 
• 1441786-45-3 methyl 4-((2-methyl-1,2,3,4-tetrahydropyrimido[1,6-a]indol-5-yl)thio)benzoate 
• 1441784-20-8 N-hydroxy-4-((2-methyl-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indol-10-yl)thio)benzamide 
• 1441786-89-5 methyl 4-((2-methyl-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indol-10-yl)thio)benzoate 
• 88489-73-0 4-(1,1,1,3,3,3-Hexafluoro-2-trifluoromethyl-propane-2-sulfonyl)-benzoic acid methyl ester 
• 88489-65-0 methyl p-(perfluoro-tert-butylthio)benzoate 

Relevant academic research and scientific papers

HETEROCYCLIC AMIDES COMPOUNDS WHICH ARE HDAC6 INHIBITORS AND USED AS ANTI-TUMORAL AGENTS

The present document describes compounds of Formula I, pharmaceutical compositions comprising the same as well as methods of treating diseases such as a cancer, neurological disease, neurodegenerative disorder, stroke, traumatic brain injury, parasitic in

Cyclization of N-butyl-4-pentenylaminyl: Implications for the cyclization of alkenylaminyl radicals

The utility of arenesulfenamides as aminyl radical precursors has been clearly demonstrated. The cyclization of N-butyl-4-pentenylaminyl is shown to be a slow and irreversible process that is accelerated significantly by small amounts of bis(tributyltin) oxide.